Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests
Rapid and accurate contact tracing required in the coming period Now that the Cabinet is relaxing the measures to combat the novel coronavirus step by step, people will go outside more frequently. The chance of the virus spreading again will then increase.
Clear impact achieved by national measures to combat the COVID-19 epidemic To monitor the effect of the measures against the spread of the novel coronavirus, the time when reported COVID-19 patients became ill was examined.
Patient in Radboudumc not contaminated with the Ebola virus The patient, who was admitted in the Radboud univerisity medical center over the past few days because of a suspected Ebola infection, was proven not to be infected.
Outbreak of avian influenza A (H5N8) in Dutch poultry In November 2014 avian ‘flu has been detected on poultry farms in the Netherlands.
Promising biobased alternatives to substances of very high concern There are many possible biobased alternatives to substances of very high concern (SVHC). Some are even ready to be deployed right away.
European Antibiotic Awareness Day 2014 Tuesday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe, attention is focused on the responsible use of antibiotics for people and animals.
Partnering as effective strategy to bring new drugs to European market Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f
Dr. ZhiChao Dang appointed honorary professor in China Dr. ZhiChao Dang of the National Institute of Public Health and Environment (RIVM) was appointed honorary professor at the highly renowned Nanjing Institute of Environmental Sciences (NIES).
The National Immunisation Programme in the Netherlands 2013 - 2014 Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).